Beijing Leadman Biochemistry Co.,Ltd. (300289.SZ)
CNY 5.52
(-0.18%)
CNY 5.52
(-0.18%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -546.85 Million CNY | 26.07% |
| 2022 | -739.67 Million CNY | 12.91% |
| 2021 | -849.31 Million CNY | -194.32% |
| 2020 | -288.56 Million CNY | -20.65% |
| 2019 | -239.17 Million CNY | -56.46% |
| 2018 | -152.86 Million CNY | -9.69% |
| 2017 | -139.35 Million CNY | -179.08% |
| 2016 | -49.93 Million CNY | -21.31% |
| 2015 | -41.16 Million CNY | -166.84% |
| 2014 | 61.58 Million CNY | 167.44% |
| 2013 | -91.31 Million CNY | 50.84% |
| 2012 | -185.74 Million CNY | -359.99% |
| 2011 | 71.44 Million CNY | 338.45% |
| 2010 | -29.96 Million CNY | -68.35% |
| 2009 | -17.79 Million CNY | 23.29% |
| 2008 | -23.2 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -387.72 Million CNY | 46.17% |
| 2024 Q1 | -728.72 Million CNY | -33.26% |
| 2024 Q2 | -726.35 Million CNY | 0.33% |
| 2023 Q2 | -530.5 Million CNY | 30.69% |
| 2023 Q3 | -608.2 Million CNY | -14.65% |
| 2023 Q4 | -546.85 Million CNY | 10.09% |
| 2023 Q1 | -765.46 Million CNY | -3.49% |
| 2023 FY | -546.85 Million CNY | 26.07% |
| 2022 Q3 | -593.42 Million CNY | 32.99% |
| 2022 Q1 | -529.52 Million CNY | 37.65% |
| 2022 FY | -739.67 Million CNY | 12.91% |
| 2022 Q4 | -739.67 Million CNY | -24.64% |
| 2022 Q2 | -885.59 Million CNY | -67.24% |
| 2021 Q1 | -280.44 Million CNY | 2.81% |
| 2021 Q4 | -849.31 Million CNY | 0.49% |
| 2021 Q2 | -296.3 Million CNY | -5.66% |
| 2021 Q3 | -853.5 Million CNY | -188.05% |
| 2021 FY | -849.31 Million CNY | -194.32% |
| 2020 Q2 | -241.18 Million CNY | -6.56% |
| 2020 FY | -288.56 Million CNY | -20.65% |
| 2020 Q4 | -288.56 Million CNY | -2.45% |
| 2020 Q1 | -226.32 Million CNY | 5.37% |
| 2020 Q3 | -281.66 Million CNY | -16.79% |
| 2019 Q3 | -187.88 Million CNY | -3.48% |
| 2019 Q2 | -181.57 Million CNY | -1.51% |
| 2019 Q1 | -178.87 Million CNY | -17.02% |
| 2019 FY | -239.17 Million CNY | -56.46% |
| 2019 Q4 | -239.17 Million CNY | -27.3% |
| 2018 Q2 | -166.77 Million CNY | -43.24% |
| 2018 FY | -152.86 Million CNY | -9.69% |
| 2018 Q4 | -152.86 Million CNY | -24.08% |
| 2018 Q3 | -123.19 Million CNY | 26.13% |
| 2018 Q1 | -116.42 Million CNY | 16.45% |
| 2017 Q2 | -85 Million CNY | -99.38% |
| 2017 Q4 | -139.35 Million CNY | -67.22% |
| 2017 Q3 | -83.33 Million CNY | 1.96% |
| 2017 FY | -139.35 Million CNY | -179.08% |
| 2017 Q1 | -42.63 Million CNY | 14.62% |
| 2016 Q1 | -38.86 Million CNY | 5.6% |
| 2016 Q4 | -49.93 Million CNY | -27.82% |
| 2016 Q3 | -39.06 Million CNY | -30.77% |
| 2016 Q2 | -29.87 Million CNY | 23.13% |
| 2016 FY | -49.93 Million CNY | -21.31% |
| 2015 Q1 | 47.8 Million CNY | -22.38% |
| 2015 Q2 | 37.16 Million CNY | -22.26% |
| 2015 Q3 | 1.73 Million CNY | -95.32% |
| 2015 FY | -41.16 Million CNY | -166.84% |
| 2015 Q4 | -41.16 Million CNY | -2468.43% |
| 2014 Q4 | 61.58 Million CNY | 189.07% |
| 2014 Q3 | -69.14 Million CNY | -77.34% |
| 2014 FY | 61.58 Million CNY | 167.44% |
| 2014 Q1 | -71.5 Million CNY | 21.7% |
| 2014 Q2 | -38.98 Million CNY | 45.47% |
| 2013 Q1 | -166.45 Million CNY | 10.39% |
| 2013 Q4 | -91.31 Million CNY | 21.21% |
| 2013 Q3 | -115.9 Million CNY | 8.37% |
| 2013 Q2 | -126.48 Million CNY | 24.01% |
| 2013 FY | -91.31 Million CNY | 50.84% |
| 2012 Q1 | -350.73 Million CNY | -590.92% |
| 2012 Q2 | -280.22 Million CNY | 20.1% |
| 2012 FY | -185.74 Million CNY | -359.99% |
| 2012 Q3 | -218.56 Million CNY | 22.0% |
| 2012 Q4 | -185.74 Million CNY | 15.01% |
| 2011 Q4 | 71.44 Million CNY | 0.0% |
| 2011 Q2 | -10.95 Million CNY | 0.0% |
| 2011 FY | 71.44 Million CNY | 338.45% |
| 2010 FY | -29.96 Million CNY | -68.35% |
| 2009 FY | -17.79 Million CNY | 23.29% |
| 2008 FY | -23.2 Million CNY | 0.0% |